2020. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s93. DOI:https://doi.org/10.25251/skin.4.supp.93.